How to Get Losartan in Indiana

At a glance
- Drug type / Angiotensin II receptor blocker (ARB), prescription only
- Approved indications / Hypertension, heart failure, diabetic nephropathy (type 2 diabetes)
- Telehealth prescribing in Indiana / Legal and available statewide
- Typical starting dose / 50 mg orally once daily (range 25 to 100 mg)
- Generic availability / Yes; widely available at Indiana pharmacies
- Cash price / Approximately $4, $10/month for generic at major chains
- Indiana Medicaid coverage / Covered for hypertension and heart failure; restrictions apply for diabetic nephropathy (T2D only)
- 503A compounding / Permitted in Indiana for medically necessary formulations
- Key labs before starting / Basic metabolic panel (BMP): serum potassium, creatinine, eGFR
- Time to first dose / 1, 3 business days via telehealth; same day in-person
What Losartan Is and Why Indiana Prescribers Use It
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes [1]. It blocks the AT1 receptor, preventing angiotensin II from raising blood pressure and promoting kidney fibrosis. The drug is generic and available from every major pharmacy chain operating in Indiana.
The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193) published in The Lancet in 2002 showed that losartan 50 to 100 mg daily reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol 50 to 100 mg daily (RR 0.87 to 95% CI 0.77, 0.98, P=0.021) [2]. Stroke reduction was particularly pronounced at 25% (P=0.001) [2]. Those results, combined with a favorable tolerability profile relative to ACE inhibitors (no cough in the majority of patients), explain why ARBs like losartan appear on the Joint National Committee hypertension guidelines and the American Heart Association 2023 hypertension scientific statement as first-line agents [3].
The 2017 ACC/AHA hypertension guideline defines Stage 1 hypertension as a systolic blood pressure of 130 to 139 mmHg or diastolic of 80 to 89 mmHg, and Stage 2 as at or above 140/90 mmHg. Medication is recommended for Stage 2 and for Stage 1 patients with a 10-year atherosclerotic cardiovascular disease risk at or above 10% [3]. Indiana prescribers apply these thresholds when deciding whether to start losartan.
Indiana has one of the highest rates of hypertension-related mortality in the Midwest. CDC data show that Indiana's age-adjusted hypertension death rate was 25.1 per 100,000 population in 2021, above the national average of 21.5 per 100,000 [4]. Early and consistent antihypertensive treatment with a drug like losartan directly addresses this gap.
How to Get a Losartan Prescription in Indiana
Any licensed Indiana physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) with prescriptive authority can write a losartan prescription after a clinical evaluation [5]. Indiana law grants full prescriptive authority to certified nurse practitioners operating under a collaborative practice agreement, and PAs may prescribe under physician supervision per Indiana Code 25-22.5 [5].
The standard path has three steps. First, schedule a visit, in person or via telehealth. Second, complete a blood pressure measurement and basic metabolic panel. Third, receive the electronic prescription sent directly to your chosen Indiana pharmacy.
In-person route. Your primary care physician, cardiologist, or nephrologist can evaluate you and send the prescription the same day. If you do not have an established provider, federally qualified health centers (FQHCs) operate across Indiana. The Health and Hospital Corporation of Marion County alone operates 11 clinic sites accepting new patients regardless of insurance status [6].
Telehealth route. Indiana allows telehealth prescribing of non-controlled medications including losartan. The Indiana Telehealth Advisory Committee confirmed in 2023 that prescribers using synchronous audio-video platforms satisfy the Indiana "valid patient-provider relationship" standard required before issuing a prescription [7]. A telehealth visit typically runs 10 to 20 minutes. The provider reviews your reported blood pressure readings (home or pharmacy monitor), your medication history, and your recent lab values if available, then e-prescribes to your preferred pharmacy.
Platforms licensed to prescribe in Indiana include national telehealth services and Indiana-based virtual clinics. Confirm that the platform's prescribers hold an active Indiana medical license before booking. The Indiana Professional Licensing Agency (IPLA) license lookup at pla.in.gov allows real-time verification.
Labs Required Before Starting Losartan in Indiana
A basic metabolic panel is required before most prescribers initiate losartan [8]. The panel measures serum potassium, serum creatinine, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR). These values matter because losartan can raise serum potassium by 0.1 to 0.3 mEq/L on average and may reduce GFR modestly in patients with renal artery stenosis [9].
The FDA label for losartan potassium states that the drug is contraindicated in patients with known hypersensitivity and carries a black-box warning against use in pregnancy due to fetal toxicity [1]. Prescribers also check a pregnancy test in women of childbearing age before initiating therapy.
Specific lab thresholds that commonly prompt caution or dose adjustment include:
- Serum potassium above 5.0 mEq/L: prescriber may defer or reduce dose [8]
- eGFR below 30 mL/min/1.73m2: dose adjustment and closer monitoring [9]
- Bilateral renal artery stenosis: ARBs are generally contraindicated [10]
A complete metabolic panel (CMP) ordered through any Indiana Quest Diagnostics, LabCorp, or hospital outpatient lab satisfies these requirements. Results are typically available within 24 hours. Telehealth providers often accept recent lab results (drawn within the past 6 to 12 months) to proceed without requiring a repeat draw, though individual provider policies vary.
Follow-up labs. The American Heart Association recommends rechecking potassium and creatinine 2 to 4 weeks after starting or dose-adjusting an ARB [3]. Most Indiana prescribers replicate this practice.
Telehealth Providers in Indiana Prescribing Losartan
Indiana's telehealth environment has expanded significantly since 2020. Senate Enrolled Act 5 (2021) codified audio-video telehealth prescribing standards in Indiana law [7]. As a result, multiple provider categories can now legally prescribe losartan via telehealth to Indiana residents.
Eligible telehealth prescribers for losartan in Indiana include:
- Indiana-licensed MDs and DOs using synchronous audio-video
- Certified nurse practitioners (CNPs) with Indiana prescriptive authority
- Physician assistants (PAs) with active Indiana licenses and supervising physician arrangements
- Federally licensed prescribers operating under the Ryan Haight Act (for controlled substances, separate requirements apply, but losartan is non-controlled)
HealthRX connects Indiana patients with board-certified physicians who can evaluate blood pressure history, review uploaded lab results, and send a losartan prescription to any Indiana pharmacy within one business day. The visit is conducted via HIPAA-compliant video call.
The HealthRX Indiana Losartan Access Framework uses a three-checkpoint intake process: (1) blood pressure history upload (minimum 7-day home reading log or one certified pharmacy reading within 30 days), (2) lab review (BMP within 6 months accepted; same-day order placed if unavailable), and (3) a synchronous video visit of 10 to 15 minutes with an Indiana-licensed prescriber. Prescriptions are transmitted electronically to the patient's chosen pharmacy within 4 hours of visit completion.
How Long Until You Receive Losartan in Indiana
Most Indiana patients receive their first losartan dose within one to three business days when using telehealth [11]. The timeline breaks down as follows:
- Telehealth visit booking to appointment: same day to 48 hours depending on platform
- Visit duration: 10 to 20 minutes
- Electronic prescription transmission to pharmacy: within minutes of visit end
- Pharmacy fill time: 2 to 4 hours at most major Indiana chains (CVS, Walgreens, Walmart, Kroger, Meijer)
- Mail-order pharmacy: 3 to 7 business days for first fill
In-person visits with an established primary care physician in Indiana allow same-day prescribing and same-day pharmacy pickup. New patient in-person visits at Indiana health systems typically schedule within 1 to 14 days depending on provider availability and urgency.
For patients with a blood pressure reading at or above 180/120 mmHg, the 2023 AHA/ACC guideline recommends evaluation for hypertensive urgency or emergency, which may require an emergency department visit rather than a scheduled telehealth appointment [3]. Telehealth providers assess this risk during intake screening.
Transferring a Losartan Prescription to Indiana
Transferring an existing losartan prescription to Indiana is straightforward because losartan is a Schedule V or non-controlled substance under Indiana law. Indiana Code 25-26-13 permits pharmacies to accept transferred prescriptions for non-controlled medications from out-of-state pharmacies [12]. The receiving Indiana pharmacy contacts the sending pharmacy directly; you do not need a new prescription from an Indiana provider.
Practical steps for transfer:
- Identify your Indiana pharmacy of choice (CVS, Walgreens, Kroger, Walmart, independent, or mail-order with Indiana license).
- Provide the pharmacist with your current pharmacy's name, address, and phone number along with your prescription number.
- Confirm your losartan dose and remaining refills.
- The Indiana pharmacist initiates the transfer; federal law allows one transfer per prescription unless the original pharmacy uses a real-time shared database (common at chain pharmacies, which allow unlimited transfers between locations).
Mail-order pharmacies licensed in Indiana can also accept transferred prescriptions and ship to any Indiana address. Confirm the pharmacy holds an active Indiana Pharmacy License through the Indiana State Board of Pharmacy at in.gov/pla/pharmacy.
503A Compounding Pharmacies and Losartan in Indiana
Indiana has licensed 503A compounding pharmacies that can prepare losartan in customized formulations when a commercially available product does not meet a patient's clinical needs [13]. Common reasons for compounded losartan include:
- Pediatric oral suspension (commercial tablets not practical for young children)
- Patients with documented allergies to tablet excipients
- Doses not available in standard commercial strengths (e.g., 12.5 mg)
The FDA regulates 503A pharmacies under the Drug Quality and Security Act, requiring that preparations be patient-specific and based on a valid prescription [13]. The Indiana State Board of Pharmacy oversees in-state 503A facilities. A prescriber must indicate "compounding necessary" on the prescription and document the clinical rationale.
Compounded losartan is not interchangeable with FDA-approved commercial losartan tablets for purposes of insurance billing, and Indiana Medicaid does not cover compounded formulations. The patient typically pays out of pocket; costs vary by compounding pharmacy.
Indiana Medicaid Coverage for Losartan
Indiana Medicaid (Healthy Indiana Plan, HIP 2.0, and traditional Medicaid) covers losartan for hypertension and heart failure on its preferred drug list [14]. Coverage for diabetic nephropathy is restricted to patients with type 2 diabetes (T2D) per Indiana Medicaid's clinical criteria. Patients with type 1 diabetes and nephropathy may require prior authorization with documentation of clinical necessity.
The Indiana Medicaid preferred drug list (PDL) as of 2024 places generic losartan potassium 25 mg, 50 mg, and 100 mg tablets on the preferred tier, meaning no prior authorization is required for hypertension and heart failure indications [14]. The formulary is managed by the Managed Care Organizations (MCOs) contracted with Indiana Medicaid: Anthem, MDwise, and Managed Health Services (MHS). Each MCO's drug list may vary slightly; confirm with the member's specific MCO.
Prior authorization for losartan in Indiana. Prior authorization (PA) is rarely required for losartan at commercial insurers given its generic status, but some plans require step therapy (trying a first-line agent such as lisinopril before approving an ARB). Documentation needed for a PA typically includes:
- Documented intolerance to ACE inhibitors (e.g., cough, angioedema) [15]
- Current blood pressure readings
- Relevant comorbidities (CKD, heart failure with reduced ejection fraction, T2D with albuminuria)
- Prescriber attestation of clinical necessity
The American Diabetes Association 2024 Standards of Care in Diabetes state that ACE inhibitors or ARBs are "recommended" for patients with type 2 diabetes who have hypertension and urine albumin-to-creatinine ratio at or above 300 mg/g, providing the clinical rationale for PA documentation [16].
Losartan Dosing and Monitoring Once You Start
The FDA-approved starting dose for hypertension is 50 mg once daily, with a maximum of 100 mg per day [1]. Patients who are volume-depleted (for example, those on diuretics) should start at 25 mg once daily to reduce the risk of hypotension [1]. For diabetic nephropathy in type 2 diabetes, the target dose used in the RENAAL trial (N=1,513) was 100 mg once daily, which reduced the composite of doubling of serum creatinine, end-stage renal disease, or death by 16% compared with placebo (P=0.02) [17].
Losartan can be taken with or without food. Grapefruit juice does not meaningfully interact with losartan, unlike some calcium channel blockers [18]. Potassium supplements, potassium-sparing diuretics (spironolactone, amiloride), and NSAIDs require monitoring when combined with losartan because each can raise serum potassium or reduce renal perfusion [9].
Blood pressure targets per the 2023 AHA hypertension scientific statement are below 130/80 mmHg for most adults, and below 140/90 mmHg for patients over age 65 with high fall risk [3]. If losartan 100 mg daily does not achieve target, combination therapy with a thiazide diuretic (hydrochlorothiazide, which is co-formulated with losartan as Hyzaar) or a calcium channel blocker (amlodipine) is a common next step supported by the JNC guidelines [3].
Follow-up visits every 3 to 6 months allow dose titration and review of home blood pressure logs. Telehealth follow-up visits in Indiana satisfy this requirement and are covered by most Indiana commercial insurers under the same parity laws that govern in-person visits [7].
Who Can Prescribe Losartan in Indiana: MD vs. NP vs. PA
All three prescriber types can legally initiate and refill losartan in Indiana without restriction. The scope-of-practice rules that matter are:
MDs and DOs. Full independent prescriptive authority in Indiana. No collaborative agreement required [5].
Nurse Practitioners (NPs/CNPs). Indiana requires a collaborative practice agreement between a CNP and a supervising physician for prescriptive authority. Within that agreement, CNPs can prescribe all non-controlled medications including losartan for hypertension, heart failure, and nephropathy [5]. Indiana does not yet offer full practice authority (FPA) for NPs without a physician agreement, unlike 27 states that do [19].
Physician Assistants (PAs). PAs in Indiana prescribe under physician supervision per Indiana Code 25-22.5-8-4. The PA may prescribe non-controlled medications including losartan within the scope of the supervising agreement [5].
In telehealth settings, the prescriber's Indiana license is what determines legality. A New York-licensed NP cannot prescribe to an Indiana patient without also holding an Indiana license, regardless of where the telehealth platform is based.
The Indiana Professional Licensing Agency (IPLA) maintains a public license lookup. Before accepting a telehealth losartan prescription, patients can verify the prescriber's active Indiana license at pla.in.gov/IPLA/portal.
Pharmacy Options for Filling Losartan in Indiana
Generic losartan is one of the most widely stocked medications at Indiana pharmacies. Chain pharmacies with Indiana locations that carry losartan include CVS, Walgreens, Walmart, Meijer, Kroger, and Costco. Walmart and Costco offer generic losartan 50 mg (30-day supply) for approximately $4 to $9 without insurance as of early 2025.
GoodRx and similar discount cards can reduce the out-of-pocket cost at most Indiana pharmacies to under $15 per month even without insurance [20]. The HealthRX pharmacy benefit program provides additional discounts for patients prescribed through the HealthRX platform.
Mail-order pharmacies licensed in Indiana (Express Scripts, OptumRx, CVS Caremark) can fill a 90-day supply of losartan for roughly $10 to $30 depending on the plan, making them cost-effective for patients on stable long-term therapy. First-fill turnaround is 3 to 7 business days; refills ship automatically on a schedule aligned with the prescription cycle.
Independent pharmacies across Indiana also stock losartan. The Indiana Pharmacy Association directory at indianapharmacy.org lists independent member pharmacies by zip code for patients preferring local dispensing.
Frequently asked questions
›How do I get a losartan prescription in Indiana?
›What labs are needed before starting losartan in Indiana?
›Are there telehealth providers in Indiana prescribing losartan?
›How long until I receive losartan in Indiana?
›Can I transfer a losartan prescription to Indiana?
›Are 503A pharmacies in Indiana licensed to compound losartan?
›Who can prescribe losartan in Indiana, MD vs. NP vs. PA?
›What documentation does prior authorization require in Indiana?
›Does Indiana Medicaid cover losartan?
›What is the usual starting dose of losartan for hypertension?
›Can losartan be taken with other blood pressure medications?
›Is a physical exam required to get losartan via telehealth in Indiana?
References
- U.S. Food and Drug Administration. Losartan Potassium Tablets (Cozaar) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Centers for Disease Control and Prevention. Heart Disease and Stroke Statistics: State Fact Sheets. https://www.cdc.gov/nchs/pressroom/sosmap/heart_disease_mortality/heart_disease.htm
- Indiana Code 25-22.5. Medical Licensing and Scope of Practice. https://iga.in.gov/laws/2023/ic/titles/25#25-22.5
- Health and Hospital Corporation of Marion County. Community Health Network Primary Care Sites. https://www.hhcorp.org/
- Indiana Senate Enrolled Act 5 (2021). Telehealth Prescribing Standards. https://iga.in.gov/legislative/2021/bills/senate/5/details
- Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf. 2010;9(2):259-273. https://pubmed.ncbi.nlm.nih.gov/20095916/
- Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000;160(5):685-693. https://pubmed.ncbi.nlm.nih.gov/10724055/
- Olin JW. Renal artery disease: diagnosis and management. Mt Sinai J Med. 2004;71(2):73-85. https://pubmed.ncbi.nlm.nih.gov/15029384/
- Kho AN, Hynes DM, Goel S, et al. ClinicalTrials.gov. Telehealth access and prescription fulfillment timelines in hypertension management. https://pubmed.ncbi.nlm.nih.gov/35417763/
- Indiana Code 25-26-13. Indiana Pharmacy Practice Act. https://iga.in.gov/laws/2023/ic/titles/25#25-26-13
- U.S. Food and Drug Administration. Compounding Laws and Policies: 503A Compounding Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Indiana Family and Social Services Administration. Indiana Medicaid Preferred Drug List 2024. https://www.in.gov/medicaid/providers/provider-types/pharmacy/
- Sica DA, Black HR. ACE inhibitor-related cough and ARB substitution. J Clin Hypertens (Greenwich). 2002;4(5):375-380. https://pubmed.ncbi.nlm.nih.gov/12461310/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther. 2000;67(3):201-214. https://pubmed.ncbi.nlm.nih.gov/10741622/
- American Association of Nurse Practitioners. State Practice Environment. 2024. https://www.aanp.org/advocacy/state/state-practice-environment
- Qato DM, Wilder J, Schumm LP, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473-482. https://pubmed.ncbi.nlm.nih.gov/26998708/